THC Therapeutics, Inc. Share Price

Equities

THCT

US87248Q1013

Heavy Machinery & Vehicles

Delayed OTC Markets 19:50:34 21/05/2024 BST 5-day change 1st Jan Change
0.0033 USD 0.00% Intraday chart for THC Therapeutics, Inc. 0.00% 0.00%
Sales 2022 - Sales 2023 - Capitalization 102K 8.05M
Net income 2022 -1M -78.55M Net income 2023 - 0 EV / Sales 2022 -
Net Debt 2022 946K 74.28M Net Debt 2023 791K 62.16M EV / Sales 2023 -
P/E ratio 2022
-0.57 x
P/E ratio 2023
-0.25 x
Employees 1
Yield 2022 *
-
Yield 2023
-
Free-Float 69.16%
More Fundamentals * Assessed data
Dynamic Chart
1 month+3.12%
3 months-28.26%
More quotes
1 week
0.00
Extreme 0.0033
0.00
1 month
0.00
Extreme 0.0033
0.00
Current year
0.00
Extreme 0
0.01
1 year
0.00
Extreme 0
0.01
3 years
0.00
Extreme 0
0.40
5 years
0.00
Extreme 0
8.60
10 years
0.00
Extreme 0
19.40
More quotes
Managers TitleAgeSince
Chief Executive Officer 51 28/09/23
Founder 50 30/04/07
Chief Tech/Sci/R&D Officer - 12/04/17
Members of the board TitleAgeSince
Founder 50 30/04/07
Chief Executive Officer 51 28/09/23
More insiders
Date Price Change Volume
21/05/24 0.0033 0.00% 12,001
17/05/24 0.0033 0.00% 10,100

Delayed Quote OTC Markets, May 21, 2024 at 07:50 pm

More quotes
THC Therapeutics, Inc. is focused on developing a sanitizing herb dryer, the dHydronator, with multiple design, function, and usage patents. The dHydronator product is specifically designed for the drying and sanitizing (i.e., reducing the bacterial count by using ultraviolet light) of freshly harvested cannabis, and other herbs, flowers, and tea leaves. The dHydronator can reduce the moisture content of cannabis to 10-15% in only 10-14 hours. The dHydronator can also reduce the bacterial count of the cannabis during the drying process. The Company operates in the wellness industry.
More about the company